Savara Reports Fourth Quarter / Year-End 2022 Financial Results and Provides Business Update

Author's Avatar
Mar 30, 2023

Savara+Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the fourth quarter and full year ending December 31, 2022 and provided a business update.